Literature DB >> 15523749

Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke.

M McDonagh, S Carson, J Ash, B S Russman, P Z Stavri, K P Krages, M Helfand.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 15523749      PMCID： PMC4781433          DOI： 10.1037/e439262005-001

Source DB:  PubMed          Journal:  Evid Rep Technol Assess (Summ)        ISSN： 1530-440X


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic interventions in cerebral palsy.

Authors:  Dilip R Patel
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

2.  Brief report: Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: a clinical trial.

Authors:  Stephen Bent; Kiah Bertoglio; Paul Ashwood; Edward Nemeth; Robert L Hendren
Journal:  J Autism Dev Disord       Date:  2012-06

Review 3.  Complementary and alternative medicine treatments for children with autism spectrum disorders.

Authors:  Susan E Levy; Susan L Hyman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

4.  The Effect of Hyperbaric Oxygen Therapy on Functional Impairments Caused by Ischemic Stroke.

Authors:  Emily R Rosario; Stephanie E Kaplan; Sepehr Khonsari; Garrett Vazquez; Niyant Solanki; Melanie Lane; Hiriam Brownell; Sheila S Rosenberg
Journal:  Neurol Res Int       Date:  2018-10-09

5.  Hyperbaric oxygen therapy to improve cognitive dysfunction and encephalatrophy induced by N2O for recreational use: a case report.

Authors:  Dan Luo; Jiajun Xu; Li Hu; Liangming Yu; Leling Xie; Jing Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-03       Impact factor: 2.570

6.  Hyperbaric oxygen in children with cerebral palsy: A systematic review of effectiveness and safety.

Authors:  Justine Laureau; Christelle Pons; Guy Letellier; Raphaël Gross
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

7.  Traumatic brain injury: future assessment tools and treatment prospects.

Authors:  Steven R Flanagan; Joshua B Cantor; Teresa A Ashman
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.